| CTSO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CTSO shares outstanding history going back to 12/5/2014:
Also see: CTSO Market Cap History CTSO YTD Return |
CTSO Shares Outstanding History — Cytosorbents Share Count Over Time
As of 3/20/2026 Cytosorbents has 62.70 million CTSO shares outstanding. Investors often track the CTSO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CTSO share count trends over time, with 45 historical shares outstanding datapoints presented, dating back to 12/5/2014.
| CTSO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CTSO Historical Shares Outstanding: +9.17% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CTSO Stock Price Chart |
| About Cytosorbents Corp |
| CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care (ICU) and cardiac surgery using blood purification via its proprietary polymer adsorption technology. Co.'s flagship product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury, cytokine release syndrome due to cancer immunotherapy, and pancreatitis. Its other products include CytoSorb, animal-targeted VetResQ, DrugSorb-ATR and ECOS-300CY. We show 45 historical shares outstanding datapoints in our coverage of CTSO's shares outstanding history. Understanding the changing numbers of CTSO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CTSO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CTSO by allowing them to research CTSO shares outstanding history as well as any other stock in our coverage universe. |
| CTSO Current Stock Quote |
Quotes delayed 20 minutes  Free CTSO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CTSO Share Performance |
| Shares Outstanding Peers |
| Cytosorbents (CTSO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CTXR Shares Outstanding History CUE Shares Outstanding History CUR Shares Outstanding History CUTR Shares Outstanding History CVKD Shares Outstanding History CVRX Shares Outstanding History CVS Shares Outstanding History CWBR Shares Outstanding History CYCC Shares Outstanding History CYCN Shares Outstanding History More Healthcare companies » |
CTSO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
